niman

For a complete breakdown of non-travel and travel-related Zika infections to-date, please see below. Infection Type Infection Count Travel-Related Infections of Zika 336 Non-Travel Related Infections of Zika 15 Infections Involving Pregnant Women 55 NUMBER OF ZIKA CASES BY COUNTY County Number of Cases (all travel related) Alachua 5 Brevard 8 Broward 55 Charlotte 1 Citrus 2 Clay 3 Collier 4 Duval 6 Escambia 2 Highlands 1 Hillsborough 10 Lake 1 Lee 6 Manatee 2 Martin 1 Miami-Dade 102 Okaloosa 2 Okeechobee 1 Orange 40 Osceola 18 Palm Beach 18 Pasco 6 Pinellas 7 Polk 12 Santa Rosa 1 Seminole 12 St. Johns 3 St. Lucie 2 Volusia 5 Total cases not involving pregnant women 336 . . . . . . Cases involving pregnant women regardless of symptoms 55 Lasted updated: Aug. 2, 2016 - 4pm EST

Map Update https://www.google.com/maps/d/edit?hl=en&hl=en&authuser=0&authuser=0&mid=1FlIB7hHnVgGD9TlbSx5HwAj-PEQ

August 2, 2016 DEPARTMENT OF HEALTH DAILY ZIKA UPDATE Contact: Communications [email protected] (850) 245-4111 Tallahassee, Fla.—In an effort to keep Florida residents and visitors safe and aware about the status of the Zika virus, the department will continue to issue a Zika virus update each week day at 2 p.m. Updates will include a CDC-confirmed Zika case count by county and information to better keep Floridians prepared. There are three new travel-related cases today and all are located in Miami-Dade County. Please visit ourwebsite to see the full list of travel-related cases. The department is investigating one new non-travel related infection in Miami-Dade County. The total number of non-travel related infections is 15 and all are in Miami-Dade and Broward County. THE DEPARTMENT STILL BELIEVES ACTIVE TRANSMISSION IS ONLY TAKING PLACE WITHIN THE IDENTIFTIED ONE-SQUARE MILE AREA IN MIAMI-DADE COUNTY. For a complete breakdown of non-travel and travel-related Zika infections to-date, please see below. Infection Type Infection Count Travel-Related Infections of Zika 336 Non-Travel Related Infections of Zika 15 Infections Involving Pregnant Women 55 The new non-travel related infection is located outside of the one-square mile area in Miami-Dade County where the department has identified active transmission is taking place. The investigation is on-going and the department has begun door-to-door outreach and sampling in the area of the confirmed case. Mosquito abatement and reduction activities are also taking place. The department will share more details as they become available. On Friday, July 29, the department confirmed Florida’s first local transmissions of the Zika virus in four individuals in Miami-Dade and Broward Counties. Three locations of interest were investigated based on where these individuals spent a majority of their time. Since the department began our investigation into possible local transmissions of Zika on July 7th, more than 340 individuals in Miami-Dade and Broward counties have been tested for the virus who live or work near the individuals that have already been confirmed with likely mosquito-borne transmissions. See breakdown of cases and testing numbers below. One case in Miami-Dade: 54 close contacts and individuals from the community have been tested with no additional positives One case in Broward: 70 close contacts and individuals from the community have been tested with no additional positive Two cases in the area of interest in Miami-Dade: tested 26 close contacts, one confirmed and three probable; 52 individuals from the community have been tested, six were positive but asymptomatic An additional 142 individuals in the area have been tested; one was positive but asymptomatic and had recent travel to a Zika-affected area and is considered a travel-related infection The department tested close contacts and community members within a 150 meter radius, the maximum distance that Aedes aegypti mosquitoes are known to travel. These community surveys are the first systematic assessment of individuals for possible asymptomatic Zika virus infection ever performed. Finding six asymptomatic individuals who were positive for Zika contributes to our understanding of the role these individuals may play in transmitting Zika The department has conducted testing for the Zika virus for nearly 2,400 people statewide. At this time, the department still believes active transmissions of the Zika virus are occurring in one small area in Miami-Dade County, just north of downtown. The exact location is within the boundaries of the following area: NW 5th Avenue to the west, US 1 to the east, NW/NE 38th Street to the north and NW/NE 20thStreet to the south. This area is about one square mile and a map is below to detail the area. This remains the only area of the state where the department has confirmed there are local transmissions of Zika. If investigations reveal additional areas of likely active transmission, the department will announce a defined area of concern. In the area where active transmission is occurring, the department continues door-to-door outreach and is gathering samples for testing to determine the number of people affected. Mosquito abatement and reduction activities continue. Mosquito control will be conducting aerial spraying in the area. The department continues to work closely with CDC. On August 1, the Governor directed the department to request a CDC Emergency Response Team (CERT). The CERT arrived in Florida today and they will be assisting the department with investigation, sample collection, public outreach and mosquito control efforts. CDC recommends that women who are pregnant or thinking of becoming pregnant postpone travel to areas with widespread Zika infection. Florida’s small case cluster is not considered widespread transmission, however, pregnant women are advised to avoid non-essential travel to the impacted area in Miami-Dade County (see map below). If you are pregnant and must travel or if you live or work in the impacted area, protect yourself from mosquito bites by wearing insect repellent, long clothing and limiting your time outdoors. According to CDC guidance, providers should consider testing all pregnant women with a history of travel to a Zika affected area for the virus. It is also recommended that all pregnant women who reside in or travel frequently to the area where active transmission is likely occurring be tested for Zika in the first and second trimester. Pregnant women in the identified area can contact their medical provider or their local county health department to be tested and receive a Zika prevention kit. CDC recommends that a pregnant woman with a history of Zika virus and her provider should consider additional ultrasounds. Additionally, the department will work closely with the Healthy Start Coalition of Miami-Dade County to identify pregnant women in the one square mile area to ensure they have access to resources and information to protect themselves. CDC recommends that a pregnant woman with a history of Zika virus and her provider should consider additional ultrasounds. Florida has been monitoring pregnant women with evidence of Zika regardless of symptoms since January. The total number of pregnant women who have been or are being monitored is 55. The Council of State and Territorial Epidemiologists and CDC released a new case definition for Zika that now includes reporting both asymptomatic and symptomatic cases of Zika. Prior to this change, states reported only symptomatic non-pregnant cases and pregnant cases regardless of symptoms. This change comes as a result of increased availability for testing in commercial laboratories. On Feb. 12, Governor Scott directed the State Surgeon General to activate a Zika Virus Information Hotline for current Florida residents and visitors, as well as anyone planning on traveling to Florida in the near future. The hotline, managed by the Department of Health, has assisted 2,624 callers since it launched. The number for the Zika Virus Information Hotline is 1-855-622-6735. The department urges Floridians to drain standing water weekly, no matter how seemingly small. A couple drops of water in a bottle cap can be a breeding location for mosquitoes. Residents and visitors also need to use repellents when enjoying the Florida outdoors. More Information on DOH action on Zika: On Feb. 3, Governor Scott directed the State Surgeon General to issue a Declaration of Public Health Emergency for the counties of residents with travel-associated cases of Zika.DOH encourages Florida residents and visitors to protect themselves from all mosquito-borne illnesses by draining standing water; covering their clothing and bare skin with repellent; and covering windows with screens. There have been 29 counties included in the declaration– Alachua, Brevard, Broward, Charlotte, Citrus, Clay, Collier, Duval, Escambia, Highlands, Hillsborough, Lake, Lee, Manatee, Martin, Miami-Dade, Okaloosa, Okeechobee, Orange, Osceola, Palm Beach, Pasco, Pinellas, Polk, Santa Rosa, Seminole, St. Johns, St. Lucie and Volusia – and will be updated as needed. DOH has a robust mosquito-borne illness surveillance system and is working with CDC, the Florida Department of Agriculture and Consumer Services and local county mosquito control boards to ensure that the proper precautions are being taken to protect Florida residents and visitors. On April 6, Governor Scott and Interim State Surgeon General Dr. Celeste Philip hosted a conference call with Florida Mosquito Control Districts to discuss ongoing preparations to fight the possible spread of the Zika virus in Florida. There were 74 attendees on the call. On May 11, Governor Scott met with federal leaders on the importance of preparing for Zika as we would a hurricane. Governor Scott requested 5,000 Zika preparedness kits from HHS Secretary Sylvia Burwell as well as a plan from FEMA on how resources will be allocated to states in the event an emergency is declared. On June 1, Governor Scott requested for President Obama to provide preparedness items needed in order to increase Florida’s capacity to be ready when Zika becomes mosquito-borne in our state. On June 9, Governor Scott spoke with Health and Human Services Secretary Sylvia Burwell and CDC Director Dr. Tom Frieden on Zika preparedness and reiterated the requests that he has continued to make to the federal government to prepare for the Zika virus once it becomes mosquito-borne in Florida. Governor Scott also requested that the CDC provide an additional 1,300 Zika antibody tests to Florida to allow individuals, especially pregnant women and new mothers, to see if they ever had the Zika virus. On June 23, Governor Scott announced that he will use his emergency executive authority to allocate $26.2 million in state funds for Zika preparedness, prevention and response in Florida. On June 28, the department announced the first confirmed case of microcephaly in an infant born in Florida whose mother had a travel-related case of Zika. The mother of the infant contracted Zika while in Haiti. Following the confirmation of this case, Governor Scott called on CDC to host a call with Florida medical professionals, including OBGYNs and physicians specializing in family medicine, to discuss the neurological impacts of Zika and what precautions new and expecting mothers should take. On July 1, CDC hosted a call with Florida medical professionals, including OB/GYNs, pediatricians and physicians specializing in family medicine, to discuss the neurological impacts of Zika and what precautions new and expecting mothers should take. More than 120 clinicians participated. On July 29, Governor Scott announced that the department had gathered enough information as part of its ongoing investigation into non-travel related cases of Zika in Miami-Dade and Broward counties to conclude that a high likelihood exists that four cases are the result of local transmission. The department believes that active transmission of the Zika virus is occurring in one small area in Miami-Dade County, just north of downtown. The exact location is within the boundaries of the following area: NW 5th Avenue to the west, US 1 to the east, NW/NE 38th Street to the north and NW/NE 20th Street to the south. Florida currently has the capacity to test 6,526 people for active Zika virus and 1,985 for Zika antibodies. Federal Guidance on Zika: According to CDC, Zika illness is generally mild with a rash, fever and joint pain. CDC researchers have concluded that Zika virus is a cause of microcephaly and other birth defects. The FDA released guidance regarding donor screening, deferral and product management to reduce the risk of transfusion-transmission of Zika virus. Additional information is available on the FDA website here. CDC has put out guidance related to the sexual transmission of the Zika virus. This includes CDC recommendation that if you have traveled to a country with local transmission of Zika you should abstain from unprotected sex. For more information on Zika virus, click here. About the Florida Department of Health The department, nationally accredited by the Public Health Accreditation Board, works to protect, promote and improve the health of all people in Florida through integrated state, county and community efforts. Follow us on Twitter at @HealthyFla and on Facebook. For more information about the Florida Department of Health, please visit www.FloridaHealth.gov.

An additional 142 individuals in the area have been tested; one was positive but asymptomatic and had recent travel to a Zika-affected area and is considered a travel-related infection http://www.floridahealth.gov/newsroom/2016/08/080216-zika-update.html

The entire fragment was used (238 BP)

Map Update https://www.google.com/maps/d/edit?hl=en&hl=en&authuser=0&authuser=0&mid=1FlIB7hHnVgGD9TlbSx5HwAj-PEQ

August 2, 2016 DEPARTMENT OF HEALTH DAILY ZIKA UPDATE Contact: Communications [email protected] (850) 245-4111 Tallahassee, Fla.—In an effort to keep Florida residents and visitors safe and aware about the status of the Zika virus, the department will continue to issue a Zika virus update each week day at 2 p.m. Updates will include a CDC-confirmed Zika case count by county and information to better keep Floridians prepared. There are three new travel-related cases today and all are located in Miami-Dade County. Please visit ourwebsite to see the full list of travel-related cases. The department is investigating one new non-travel related infection in Miami-Dade County. The total number of non-travel related infections is 15 and all are in Miami-Dade and Broward County. THE DEPARTMENT STILL BELIEVES ACTIVE TRANSMISSION IS ONLY TAKING PLACE WITHIN THE IDENTIFTIED ONE-SQUARE MILE AREA IN MIAMI-DADE COUNTY. For a complete breakdown of non-travel and travel-related Zika infections to-date, please see below. Infection Type Infection Count Travel-Related Infections of Zika 336 Non-Travel Related Infections of Zika 15 Infections Involving Pregnant Women 55 The new non-travel related infection is located outside of the one-square mile area in Miami-Dade County where the department has identified active transmission is taking place. The investigation is on-going and the department has begun door-to-door outreach and sampling in the area of the confirmed case. Mosquito abatement and reduction activities are also taking place. The department will share more details as they become available. On Friday, July 29, the department confirmed Florida’s first local transmissions of the Zika virus in four individuals in Miami-Dade and Broward Counties. Three locations of interest were investigated based on where these individuals spent a majority of their time. Since the department began our investigation into possible local transmissions of Zika on July 7th, more than 340 individuals in Miami-Dade and Broward counties have been tested for the virus who live or work near the individuals that have already been confirmed with likely mosquito-borne transmissions. See breakdown of cases and testing numbers below. One case in Miami-Dade: 54 close contacts and individuals from the community have been tested with no additional positives One case in Broward: 70 close contacts and individuals from the community have been tested with no additional positive Two cases in the area of interest in Miami-Dade: tested 26 close contacts, one confirmed and three probable; 52 individuals from the community have been tested, six were positive but asymptomatic An additional 142 individuals in the area have been tested; one was positive but asymptomatic and had recent travel to a Zika-affected area and is considered a travel-related infection The department tested close contacts and community members within a 150 meter radius, the maximum distance that Aedes aegypti mosquitoes are known to travel. These community surveys are the first systematic assessment of individuals for possible asymptomatic Zika virus infection ever performed. Finding six asymptomatic individuals who were positive for Zika contributes to our understanding of the role these individuals may play in transmitting Zika The department has conducted testing for the Zika virus for nearly 2,400 people statewide. At this time, the department still believes active transmissions of the Zika virus are occurring in one small area in Miami-Dade County, just north of downtown. The exact location is within the boundaries of the following area: NW 5th Avenue to the west, US 1 to the east, NW/NE 38th Street to the north and NW/NE 20thStreet to the south. This area is about one square mile and a map is below to detail the area. This remains the only area of the state where the department has confirmed there are local transmissions of Zika. If investigations reveal additional areas of likely active transmission, the department will announce a defined area of concern. In the area where active transmission is occurring, the department continues door-to-door outreach and is gathering samples for testing to determine the number of people affected. Mosquito abatement and reduction activities continue. Mosquito control will be conducting aerial spraying in the area. The department continues to work closely with CDC. On August 1, the Governor directed the department to request a CDC Emergency Response Team (CERT). The CERT arrived in Florida today and they will be assisting the department with investigation, sample collection, public outreach and mosquito control efforts. CDC recommends that women who are pregnant or thinking of becoming pregnant postpone travel to areas with widespread Zika infection. Florida’s small case cluster is not considered widespread transmission, however, pregnant women are advised to avoid non-essential travel to the impacted area in Miami-Dade County (see map below). If you are pregnant and must travel or if you live or work in the impacted area, protect yourself from mosquito bites by wearing insect repellent, long clothing and limiting your time outdoors. According to CDC guidance, providers should consider testing all pregnant women with a history of travel to a Zika affected area for the virus. It is also recommended that all pregnant women who reside in or travel frequently to the area where active transmission is likely occurring be tested for Zika in the first and second trimester. Pregnant women in the identified area can contact their medical provider or their local county health department to be tested and receive a Zika prevention kit. CDC recommends that a pregnant woman with a history of Zika virus and her provider should consider additional ultrasounds. Additionally, the department will work closely with the Healthy Start Coalition of Miami-Dade County to identify pregnant women in the one square mile area to ensure they have access to resources and information to protect themselves. CDC recommends that a pregnant woman with a history of Zika virus and her provider should consider additional ultrasounds. Florida has been monitoring pregnant women with evidence of Zika regardless of symptoms since January. The total number of pregnant women who have been or are being monitored is 55. The Council of State and Territorial Epidemiologists and CDC released a new case definition for Zika that now includes reporting both asymptomatic and symptomatic cases of Zika. Prior to this change, states reported only symptomatic non-pregnant cases and pregnant cases regardless of symptoms. This change comes as a result of increased availability for testing in commercial laboratories. On Feb. 12, Governor Scott directed the State Surgeon General to activate a Zika Virus Information Hotline for current Florida residents and visitors, as well as anyone planning on traveling to Florida in the near future. The hotline, managed by the Department of Health, has assisted 2,624 callers since it launched. The number for the Zika Virus Information Hotline is 1-855-622-6735. The department urges Floridians to drain standing water weekly, no matter how seemingly small. A couple drops of water in a bottle cap can be a breeding location for mosquitoes. Residents and visitors also need to use repellents when enjoying the Florida outdoors. More Information on DOH action on Zika: On Feb. 3, Governor Scott directed the State Surgeon General to issue a Declaration of Public Health Emergency for the counties of residents with travel-associated cases of Zika.DOH encourages Florida residents and visitors to protect themselves from all mosquito-borne illnesses by draining standing water; covering their clothing and bare skin with repellent; and covering windows with screens. There have been 29 counties included in the declaration– Alachua, Brevard, Broward, Charlotte, Citrus, Clay, Collier, Duval, Escambia, Highlands, Hillsborough, Lake, Lee, Manatee, Martin, Miami-Dade, Okaloosa, Okeechobee, Orange, Osceola, Palm Beach, Pasco, Pinellas, Polk, Santa Rosa, Seminole, St. Johns, St. Lucie and Volusia – and will be updated as needed. DOH has a robust mosquito-borne illness surveillance system and is working with CDC, the Florida Department of Agriculture and Consumer Services and local county mosquito control boards to ensure that the proper precautions are being taken to protect Florida residents and visitors. On April 6, Governor Scott and Interim State Surgeon General Dr. Celeste Philip hosted a conference call with Florida Mosquito Control Districts to discuss ongoing preparations to fight the possible spread of the Zika virus in Florida. There were 74 attendees on the call. On May 11, Governor Scott met with federal leaders on the importance of preparing for Zika as we would a hurricane. Governor Scott requested 5,000 Zika preparedness kits from HHS Secretary Sylvia Burwell as well as a plan from FEMA on how resources will be allocated to states in the event an emergency is declared. On June 1, Governor Scott requested for President Obama to provide preparedness items needed in order to increase Florida’s capacity to be ready when Zika becomes mosquito-borne in our state. On June 9, Governor Scott spoke with Health and Human Services Secretary Sylvia Burwell and CDC Director Dr. Tom Frieden on Zika preparedness and reiterated the requests that he has continued to make to the federal government to prepare for the Zika virus once it becomes mosquito-borne in Florida. Governor Scott also requested that the CDC provide an additional 1,300 Zika antibody tests to Florida to allow individuals, especially pregnant women and new mothers, to see if they ever had the Zika virus. On June 23, Governor Scott announced that he will use his emergency executive authority to allocate $26.2 million in state funds for Zika preparedness, prevention and response in Florida. On June 28, the department announced the first confirmed case of microcephaly in an infant born in Florida whose mother had a travel-related case of Zika. The mother of the infant contracted Zika while in Haiti. Following the confirmation of this case, Governor Scott called on CDC to host a call with Florida medical professionals, including OBGYNs and physicians specializing in family medicine, to discuss the neurological impacts of Zika and what precautions new and expecting mothers should take. On July 1, CDC hosted a call with Florida medical professionals, including OB/GYNs, pediatricians and physicians specializing in family medicine, to discuss the neurological impacts of Zika and what precautions new and expecting mothers should take. More than 120 clinicians participated. On July 29, Governor Scott announced that the department had gathered enough information as part of its ongoing investigation into non-travel related cases of Zika in Miami-Dade and Broward counties to conclude that a high likelihood exists that four cases are the result of local transmission. The department believes that active transmission of the Zika virus is occurring in one small area in Miami-Dade County, just north of downtown. The exact location is within the boundaries of the following area: NW 5th Avenue to the west, US 1 to the east, NW/NE 38th Street to the north and NW/NE 20th Street to the south. Florida currently has the capacity to test 6,526 people for active Zika virus and 1,985 for Zika antibodies. Federal Guidance on Zika: According to CDC, Zika illness is generally mild with a rash, fever and joint pain. CDC researchers have concluded that Zika virus is a cause of microcephaly and other birth defects. The FDA released guidance regarding donor screening, deferral and product management to reduce the risk of transfusion-transmission of Zika virus. Additional information is available on the FDA website here. CDC has put out guidance related to the sexual transmission of the Zika virus. This includes CDC recommendation that if you have traveled to a country with local transmission of Zika you should abstain from unprotected sex. For more information on Zika virus, click here. About the Florida Department of Health The department, nationally accredited by the Public Health Accreditation Board, works to protect, promote and improve the health of all people in Florida through integrated state, county and community efforts. Follow us on Twitter at @HealthyFla and on Facebook. For more information about the Florida Department of Health, please visit www.FloridaHealth.gov.

The new non-travel related infection is located outside of the one-square mile area in Miami-Dade County where the department has identified active transmission is taking place. The investigation is on-going and the department has begun door-to-door outreach and sampling in the area of the confirmed case. Mosquito abatement and reduction activities are also taking place. The department will share more details as they become available. http://www.floridahealth.gov/newsroom/2016/08/080216-zika-update.html

August 2, 2016 DEPARTMENT OF HEALTH DAILY ZIKA UPDATE http://www.floridahealth.gov/newsroom/2016/08/080216-zika-update.html Contact: Communications [email protected] (850) 245-4111 Tallahassee, Fla.—In an effort to keep Florida residents and visitors safe and aware about the status of the Zika virus, the department will continue to issue a Zika virus update each week day at 2 p.m. Updates will include a CDC-confirmed Zika case count by county and information to better keep Floridians prepared. There are three new travel-related cases today and all are located in Miami-Dade County. Please visit ourwebsite to see the full list of travel-related cases. The department is investigating one new non-travel related infection in Miami-Dade County. The total number of non-travel related infections is 15 and all are in Miami-Dade and Broward County. THE DEPARTMENT STILL BELIEVES ACTIVE TRANSMISSION IS ONLY TAKING PLACE WITHIN THE IDENTIFTIED ONE-SQUARE MILE AREA IN MIAMI-DADE COUNTY. For a complete breakdown of non-travel and travel-related Zika infections to-date, please see below. Infection Type Infection Count Travel-Related Infections of Zika 336 Non-Travel Related Infections of Zika 15 Infections Involving Pregnant Women 55 The new non-travel related infection is located outside of the one-square mile area in Miami-Dade County where the department has identified active transmission is taking place. The investigation is on-going and the department has begun door-to-door outreach and sampling in the area of the confirmed case. Mosquito abatement and reduction activities are also taking place. The department will share more details as they become available. On Friday, July 29, the department confirmed Florida’s first local transmissions of the Zika virus in four individuals in Miami-Dade and Broward Counties. Three locations of interest were investigated based on where these individuals spent a majority of their time. Since the department began our investigation into possible local transmissions of Zika on July 7th, more than 340 individuals in Miami-Dade and Broward counties have been tested for the virus who live or work near the individuals that have already been confirmed with likely mosquito-borne transmissions. See breakdown of cases and testing numbers below. One case in Miami-Dade: 54 close contacts and individuals from the community have been tested with no additional positives One case in Broward: 70 close contacts and individuals from the community have been tested with no additional positive Two cases in the area of interest in Miami-Dade: tested 26 close contacts, one confirmed and three probable; 52 individuals from the community have been tested, six were positive but asymptomatic An additional 142 individuals in the area have been tested; one was positive but asymptomatic and had recent travel to a Zika-affected area and is considered a travel-related infection The department tested close contacts and community members within a 150 meter radius, the maximum distance that Aedes aegypti mosquitoes are known to travel. These community surveys are the first systematic assessment of individuals for possible asymptomatic Zika virus infection ever performed. Finding six asymptomatic individuals who were positive for Zika contributes to our understanding of the role these individuals may play in transmitting Zika The department has conducted testing for the Zika virus for nearly 2,400 people statewide. At this time, the department still believes active transmissions of the Zika virus are occurring in one small area in Miami-Dade County, just north of downtown. The exact location is within the boundaries of the following area: NW 5th Avenue to the west, US 1 to the east, NW/NE 38th Street to the north and NW/NE 20thStreet to the south. This area is about one square mile and a map is below to detail the area. This remains the only area of the state where the department has confirmed there are local transmissions of Zika. If investigations reveal additional areas of likely active transmission, the department will announce a defined area of concern. In the area where active transmission is occurring, the department continues door-to-door outreach and is gathering samples for testing to determine the number of people affected. Mosquito abatement and reduction activities continue. Mosquito control will be conducting aerial spraying in the area. The department continues to work closely with CDC. On August 1, the Governor directed the department to request a CDC Emergency Response Team (CERT). The CERT arrived in Florida today and they will be assisting the department with investigation, sample collection, public outreach and mosquito control efforts. CDC recommends that women who are pregnant or thinking of becoming pregnant postpone travel to areas with widespread Zika infection. Florida’s small case cluster is not considered widespread transmission, however, pregnant women are advised to avoid non-essential travel to the impacted area in Miami-Dade County (see map below). If you are pregnant and must travel or if you live or work in the impacted area, protect yourself from mosquito bites by wearing insect repellent, long clothing and limiting your time outdoors. According to CDC guidance, providers should consider testing all pregnant women with a history of travel to a Zika affected area for the virus. It is also recommended that all pregnant women who reside in or travel frequently to the area where active transmission is likely occurring be tested for Zika in the first and second trimester. Pregnant women in the identified area can contact their medical provider or their local county health department to be tested and receive a Zika prevention kit. CDC recommends that a pregnant woman with a history of Zika virus and her provider should consider additional ultrasounds. Additionally, the department will work closely with the Healthy Start Coalition of Miami-Dade County to identify pregnant women in the one square mile area to ensure they have access to resources and information to protect themselves. CDC recommends that a pregnant woman with a history of Zika virus and her provider should consider additional ultrasounds. Florida has been monitoring pregnant women with evidence of Zika regardless of symptoms since January. The total number of pregnant women who have been or are being monitored is 55. The Council of State and Territorial Epidemiologists and CDC released a new case definition for Zika that now includes reporting both asymptomatic and symptomatic cases of Zika. Prior to this change, states reported only symptomatic non-pregnant cases and pregnant cases regardless of symptoms. This change comes as a result of increased availability for testing in commercial laboratories. On Feb. 12, Governor Scott directed the State Surgeon General to activate a Zika Virus Information Hotline for current Florida residents and visitors, as well as anyone planning on traveling to Florida in the near future. The hotline, managed by the Department of Health, has assisted 2,624 callers since it launched. The number for the Zika Virus Information Hotline is 1-855-622-6735. The department urges Floridians to drain standing water weekly, no matter how seemingly small. A couple drops of water in a bottle cap can be a breeding location for mosquitoes. Residents and visitors also need to use repellents when enjoying the Florida outdoors. More Information on DOH action on Zika: On Feb. 3, Governor Scott directed the State Surgeon General to issue a Declaration of Public Health Emergency for the counties of residents with travel-associated cases of Zika.DOH encourages Florida residents and visitors to protect themselves from all mosquito-borne illnesses by draining standing water; covering their clothing and bare skin with repellent; and covering windows with screens. There have been 29 counties included in the declaration– Alachua, Brevard, Broward, Charlotte, Citrus, Clay, Collier, Duval, Escambia, Highlands, Hillsborough, Lake, Lee, Manatee, Martin, Miami-Dade, Okaloosa, Okeechobee, Orange, Osceola, Palm Beach, Pasco, Pinellas, Polk, Santa Rosa, Seminole, St. Johns, St. Lucie and Volusia – and will be updated as needed. DOH has a robust mosquito-borne illness surveillance system and is working with CDC, the Florida Department of Agriculture and Consumer Services and local county mosquito control boards to ensure that the proper precautions are being taken to protect Florida residents and visitors. On April 6, Governor Scott and Interim State Surgeon General Dr. Celeste Philip hosted a conference call with Florida Mosquito Control Districts to discuss ongoing preparations to fight the possible spread of the Zika virus in Florida. There were 74 attendees on the call. On May 11, Governor Scott met with federal leaders on the importance of preparing for Zika as we would a hurricane. Governor Scott requested 5,000 Zika preparedness kits from HHS Secretary Sylvia Burwell as well as a plan from FEMA on how resources will be allocated to states in the event an emergency is declared. On June 1, Governor Scott requested for President Obama to provide preparedness items needed in order to increase Florida’s capacity to be ready when Zika becomes mosquito-borne in our state. On June 9, Governor Scott spoke with Health and Human Services Secretary Sylvia Burwell and CDC Director Dr. Tom Frieden on Zika preparedness and reiterated the requests that he has continued to make to the federal government to prepare for the Zika virus once it becomes mosquito-borne in Florida. Governor Scott also requested that the CDC provide an additional 1,300 Zika antibody tests to Florida to allow individuals, especially pregnant women and new mothers, to see if they ever had the Zika virus. On June 23, Governor Scott announced that he will use his emergency executive authority to allocate $26.2 million in state funds for Zika preparedness, prevention and response in Florida. On June 28, the department announced the first confirmed case of microcephaly in an infant born in Florida whose mother had a travel-related case of Zika. The mother of the infant contracted Zika while in Haiti. Following the confirmation of this case, Governor Scott called on CDC to host a call with Florida medical professionals, including OBGYNs and physicians specializing in family medicine, to discuss the neurological impacts of Zika and what precautions new and expecting mothers should take. On July 1, CDC hosted a call with Florida medical professionals, including OB/GYNs, pediatricians and physicians specializing in family medicine, to discuss the neurological impacts of Zika and what precautions new and expecting mothers should take. More than 120 clinicians participated. On July 29, Governor Scott announced that the department had gathered enough information as part of its ongoing investigation into non-travel related cases of Zika in Miami-Dade and Broward counties to conclude that a high likelihood exists that four cases are the result of local transmission. The department believes that active transmission of the Zika virus is occurring in one small area in Miami-Dade County, just north of downtown. The exact location is within the boundaries of the following area: NW 5th Avenue to the west, US 1 to the east, NW/NE 38th Street to the north and NW/NE 20th Street to the south. Florida currently has the capacity to test 6,526 people for active Zika virus and 1,985 for Zika antibodies. Federal Guidance on Zika: According to CDC, Zika illness is generally mild with a rash, fever and joint pain. CDC researchers have concluded that Zika virus is a cause of microcephaly and other birth defects. The FDA released guidance regarding donor screening, deferral and product management to reduce the risk of transfusion-transmission of Zika virus. Additional information is available on the FDA website here. CDC has put out guidance related to the sexual transmission of the Zika virus. This includes CDC recommendation that if you have traveled to a country with local transmission of Zika you should abstain from unprotected sex. For more information on Zika virus, click here. About the Florida Department of Health The department, nationally accredited by the Public Health Accreditation Board, works to protect, promote and improve the health of all people in Florida through integrated state, county and community efforts. Follow us on Twitter at @HealthyFla and on Facebook. For more information about the Florida Department of Health, please visit www.FloridaHealth.gov.

Map Update https://www.google.com/maps/d/edit?hl=en&hl=en&authuser=0&authuser=0&mid=1FlIB7hHnVgGD9TlbSx5HwAj-PEQ

> From: DOH COMMUNICATIONS OFFICE <[email protected]>> Date: August 2, 2016 at 4:00:07 PM EDT> Subject: DEPARTMENT OF HEALTH DAILY ZIKA> > August 2, 2016> > DEPARTMENT OF HEALTH DAILY ZIKA> UPDATE> > > Contact: > Communications Office > [email protected]> 850-245-4111> > TALLAHASSEE, Fla. – In an effort to keep Florida residents and visitors safe and aware about the status of the Zika virus, the department will continue to issue a Zika virus update each week day at 2 p.m. Updates will include a CDC-confirmed Zika case count by county and information to better keep Floridians prepared.> > There are three new travel-related cases today and all are located in Miami-Dade County. Please visit our website to see the full list of travel-related cases.> > The department is investigating one new non-travel related infection in Miami-Dade County. The total number of non-travel related infections is 15 and all are in Miami-Dade and Broward County. THE DEPARTMENT STILL BELIEVES ACTIVE TRANSMISSION IS ONLY TAKING PLACE WITHIN THE IDENTIFTIED ONE-SQUARE MILE AREA IN MIAMI-DADE COUNTY.> > For a complete breakdown of non-travel and travel-related Zika infections to-date, please see below.> > Infection Type> Infection Count> Travel-Related Infections of Zika> 336> Non-Travel Related Infections of Zika> 15> Infections Involving Pregnant Women> 55> > The new non-travel related infection is located outside of the one-square mile area in Miami-Dade County where the department has identified active transmission is taking place. The investigation is on-going and the department has begun door-to-door outreach and sampling in the area of the confirmed case. Mosquito abatement and reduction activities are also taking place. The department will share more details as they become available.> > On Friday, July 29, the department confirmed Florida’s first local transmissions of the Zika virus in four individuals in Miami-Dade and Broward Counties. Three locations of interest were investigated based on where these individuals spent a majority of their time.> > Since the department began our investigation into possible local transmissions of Zika on July 7th, more than 340 individuals in Miami-Dade and Broward counties have been tested for the virus who live or work near the individuals that have already been confirmed with likely mosquito-borne transmissions. See breakdown of cases and testing numbers below.> > • One case in Miami-Dade: 54 close contacts and individuals from the community have been tested with no additional positives > • One case in Broward: 70 close contacts and individuals from the community have been tested with no additional positive > • Two cases in the area of interest in Miami-Dade: tested 26 close contacts, one confirmed and three probable; 52 individuals from the community have been tested, six were positive but asymptomatic> o An additional 142 individuals in the area have been tested; one was positive but asymptomatic and had recent travel to a Zika-affected area and is considered a travel-related infection> > The department tested close contacts and community members within a 150 meter radius, the maximum distance that Aedes aegypti mosquitoes are known to travel. These community surveys are the first systematic assessment of individuals for possible asymptomatic Zika virus infection ever performed. Finding six asymptomatic individuals who were positive for Zika contributes to our understanding of the role these individuals may play in transmitting Zika.> > The department has conducted testing for the Zika virus for nearly 2,400 people statewide. > > At this time, the department still believes active transmissions of the Zika virus are occurring in one small area in Miami-Dade County, just north of downtown. The exact location is within the boundaries of the following area: NW 5th Avenue to the west, US 1 to the east, NW/NE 38th Street to the north and NW/NE 20thStreet to the south. This area is about one square mile and a map is below to detail the area. This remains the only area of the state where the department has confirmed there are local transmissions of Zika. If investigations reveal additional areas of likely active transmission, the department will announce a defined area of concern. > > In the area where active transmission is occurring, the department continues door-to-door outreach and is gathering samples for testing to determine the number of people affected. Mosquito abatement and reduction activities continue. Mosquito control will be conducting aerial spraying in the area.> > The department continues to work closely with CDC. On August 1, the Governor directed the department to request a CDC Emergency Response Team (CERT). The CERT arrived in Florida today and they will be assisting the department with investigation, sample collection, public outreach and mosquito control efforts.> > CDC recommends that women who are pregnant or thinking of becoming pregnant postpone travel to areas with widespread Zika infection. Florida’s small case cluster is not considered widespread transmission, however, pregnant women are advised to avoid non-essential travel to the impacted area in Miami-Dade County (see map below). If you are pregnant and must travel or if you live or work in the impacted area, protect yourself from mosquito bites by wearing insect repellent, long clothing and limiting your time outdoors. > > According to CDC guidance, providers should consider testing all pregnant women with a history of travel to a Zika affected area for the virus. It is also recommended that all pregnant women who reside in or travel frequently to the area where active transmission is likely occurring be tested for Zika in the first and second trimester. Pregnant women in the identified area can contact their medical provider or their local county health department to be tested and receive a Zika prevention kit. CDC recommends that a pregnant woman with a history of Zika virus and her provider should consider additional ultrasounds. Additionally, the department will work closely with the Healthy Start Coalition of Miami-Dade County to identify pregnant women in the one square mile area to ensure they have access to resources and information to protect themselves. CDC recommends that a pregnant woman with a history of Zika virus and her provider should consider additional ultrasounds. > > Florida has been monitoring pregnant women with evidence of Zika regardless of symptoms since January. The total number of pregnant women who have been or are being monitored is 55.> > The Council of State and Territorial Epidemiologists and CDC released a new case definition for Zika that now includes reporting both asymptomatic and symptomatic cases of Zika. Prior to this change, states reported only symptomatic non-pregnant cases and pregnant cases regardless of symptoms. This change comes as a result of increased availability for testing in commercial laboratories.> > On Feb. 12, Governor Scott directed the State Surgeon General to activate a Zika Virus Information Hotline for current Florida residents and visitors, as well as anyone planning on traveling to Florida in the near future. The hotline, managed by the Department of Health, has assisted 2,624 callers since it launched. The number for the Zika Virus Information Hotline is 1-855-622-6735.> > The department urges Floridians to drain standing water weekly, no matter how seemingly small. A couple drops of water in a bottle cap can be a breeding location for mosquitoes. Residents and visitors also need to use repellents when enjoying the Florida outdoors.> > More Information on DOH action on Zika:> · On Feb. 3, Governor Scott directed the State Surgeon General to issue a Declaration of Public Health Emergency for the counties of residents with travel-associated cases of Zika.> > o There have been 29 counties included in the declaration– Alachua, Brevard, Broward, Charlotte, Citrus, Clay, Collier, Duval, Escambia, Highlands, Hillsborough, Lake, Lee, Manatee, Martin, Miami-Dade, Okaloosa, Okeechobee, Orange, Osceola, Palm Beach, Pasco, Pinellas, Polk, Santa Rosa, Seminole, St. Johns, St. Lucie and Volusia – and will be updated as needed. > > · DOH encourages Florida residents and visitors to protect themselves from all mosquito-borne illnesses by draining standing water; covering their clothing and bare skin with repellent; and covering windows with screens.> > · DOH has a robust mosquito-borne illness surveillance system and is working with CDC, the Florida Department of Agriculture and Consumer Services and local county mosquito control boards to ensure that the proper precautions are being taken to protect Florida residents and visitors.> > · On April 6, Governor Scott and Interim State Surgeon General Dr. Celeste Philip hosted a conference call with Florida Mosquito Control Districts to discuss ongoing preparations to fight the possible spread of the Zika virus in Florida. There were 74 attendees on the call.> > · On May 11, Governor Scott met with federal leaders on the importance of preparing for Zika as we would a hurricane. Governor Scott requested 5,000 Zika preparedness kits from HHS Secretary Sylvia Burwell as well as a plan from FEMA on how resources will be allocated to states in the event an emergency is declared.> > · On June 1, Governor Scott requested for President Obama to provide preparedness items needed in order to increase Florida’s capacity to be ready when Zika becomes mosquito-borne in our state. > > · On June 9, Governor Scott spoke with Health and Human Services Secretary Sylvia Burwell and CDC Director Dr. Tom Frieden on Zika preparedness and reiterated the requests that he has continued to make to the federal government to prepare for the Zika virus once it becomes mosquito-borne in Florida. Governor Scott also requested that the CDC provide an additional 1,300 Zika antibody tests to Florida to allow individuals, especially pregnant women and new mothers, to see if they ever had the Zika virus. > > · On June 23, Governor Scott announced that he will use his emergency executive authority to allocate $26.2 million in state funds for Zika preparedness, prevention and response in Florida.> > · On June 28, the department announced the first confirmed case of microcephaly in an infant born in Florida whose mother had a travel-related case of Zika. The mother of the infant contracted Zika while in Haiti. Following the confirmation of this case, Governor Scott called on CDC to host a call with Florida medical professionals, including OBGYNs and physicians specializing in family medicine, to discuss the neurological impacts of Zika and what precautions new and expecting mothers should take.> > · On July 1, CDC hosted a call with Florida medical professionals, including OB/GYNs, pediatricians and physicians specializing in family medicine, to discuss the neurological impacts of Zika and what precautions new and expecting mothers should take. More than 120 clinicians participated.> > · On July 29, Governor Scott announced that the department had gathered enough information as part of its ongoing investigation into non-travel related cases of Zika in Miami-Dade and Broward counties to conclude that a high likelihood exists that four cases are the result of local transmission. The department believes that active transmission of the Zika virus is occurring in one small area in Miami-Dade County, just north of downtown. The exact location is within the boundaries of the following area: NW 5th Avenue to the west, US 1 to the east, NW/NE 38th Street to the north and NW/NE 20th Street to the south.> > · Florida currently has the capacity to test 6,526 people for active Zika virus and 1,985 for Zika antibodies.> > > Federal Guidance on Zika:> > · According to CDC, Zika illness is generally mild with a rash, fever and joint pain. CDC researchers have concluded that Zika virus is a cause of microcephaly and other birth defects.> > · The FDA released guidance regarding donor screening, deferral and product management to reduce the risk of transfusion-transmission of Zika virus. Additional information is available on the FDA website here.> > · CDC has put out guidance related to the sexual transmission of the Zika virus. This includes CDC recommendation that if you have traveled to a country with local transmission of Zika you should abstain from unprotected sex.> > For more information on Zika virus, click here.

Wynwood business announces temporary closure amid Zika outbreak Aug 2, 2016, 2:32pm EDT Emon ReiserReporterSouth Florida Business Journal RELATED CONTENT CDC sending Zika emergency response team to Miami Could Zika outbreak impact tourism to South Florida? 14 Zika cases discovered in Florida (Video) Wynwood/Edgewater businesses to remain open despite Zika fears BIZSPACE SPOTLIGHT SPONSOR LISTING Property Spotlight: PV|303 - Arizona’s Rising Hub For Business Expansion See All Bizspace Properties The Wynwood Yard will temporarily close in response to the Zika virus, which is believed to be actively spreading in the area through mosquitoes. The outdoor food and event venue announced its closure shortly after officials said Miami is open for business despite the outbreak. Government health officials are warning pregnant women to avoid the one-square-mile area in Miami, which includes parts of the city's Wynwood, Edgewater and Midtown areas. VIEW SLIDESHOW70 photos A skateboarder makes his way along NW 3rd Avenue in Miami's Wynwood Art District. Because of rapid development in that part of Miami, standing water on construction sites is suspected to have attracted mosquitoes carrying the virus, which could have resulted in some of the 14 confirmed cases of Zika transmitted in the U.S. On Monday, the CDC issued an unprecedented travel warning, advising pregnant women and their partners not to visit the designated region. "The Wynwood Yard will be closed today in response to the announcement about new Zika cases by the CDC, and due to the unique 100 percent outdoor nature of our venue," the company announced Tuesday. "[We] will be closed in order to better assess preparedness and in an abundance of caution, until we have more information, in order to make sure we are providing the most comfortable and secure environment we possibly can to our team and guests." It also rescheduled an Essential Oils class planned for Tuesday until Aug. 31. Representatives for the space could not confirm if it would be open tomorrow, as the business is waiting for more information. Located at 56 N.W. 29th Street, Wynwood Yard is just one of many area restaurants, breweries and other venues with large outdoor areas. For example, Wynwood Walls is a mural installation that wraps partially around Wynwood Kitchen & Bar, a major attraction in the area that is fully outdoors. Despite the outbreak of Zika in Miami and the Centers for Disease Control and Prevention sending an emergency response team to the area, Miami officials stress that it is safe to visit South Florida. "While we understand Wynwood Yard’s decision to close for the time-being, the remaining 300 businesses that make up the unique and vibrant fabric of the neighborhood continue to operate as usual," said Albert Garcia, Vice Chairman of the Wynwood Business Improvement District and Managing Principal of Wynwood Ventures, in a statement. "We welcome the public to visit the area and encourage visitors to take all CDC recommended precautions while they enjoy all that Wynwood has to offer.” Still, some companies are not as confident about conducting business there. Miami Culinary Tours announced it cancelled its weekend tours of Wynwood's restaurants and art until further notice, the Miami Heraldreported.

Eradicating Zika-spreading mosquito is proving difficult By JENNIFER KAY Aug. 2, 2016 3:19 PM EDT 8 photos Miami police officer James Bernat, right, hands a can of insect repellent to a homeless man,... Read more MIAMI (AP) — The mosquitoes spreading Zika in Miami are proving more difficult to eradicate than expected, the nation's top disease-fighter said as authorities sprayed the ground-zero neighborhood, tipped over kiddie pools and handed out cans of insect repellent to the homeless. Dr. Tom Frieden, director of the Centers for Disease Control and Prevention, said Monday that despite aggressive spraying, the mosquitoes are still present in moderately high numbers, suggesting they may be resistant to the insecticide or are managing to hide in crevices and tiny pools of water in the bustling urban neighborhood. "In Miami, aggressive mosquito control measures don't seem to be working as well as we would have liked," Frieden said. Mosquito control experts said that's no surprise to them, describing the Aedes aegypti mosquito as a "little ninja" known for sneaking up on people's ankles and capable of breeding in just a bottle cap of standing water. More from AP Rea injured in Miami debut, Marlins win 11-0 For 8 summer nights, 2 starkly different visions of America Fourteen people are believed to have become infected with Zika from bites in Miami's Wynwood arts district — the first mosquito-transmitted cases on record in the mainland U.S., which has been girding for months against the epidemic coursing through Latin America and the Caribbean. On Monday, the CDC instructed pregnant women to avoid the neighborhood, marking what is believed to be the first time in the agency's 70-year history that it warned people not to travel somewhere in the U.S. The Zika virus can cause severe brain-related defects, including disastrously small heads. At the same time, U.S. health authorities have said they don't expect major outbreaks in this country, in part because of better sanitation and the use of air conditioners and window screens. Miami-Dade County mosquito control inspectors went door to door in Wynwood on Tuesday, handing out information, checking tires and other objects for standing water, and dipping cups to take water samples from vacant lots, building sites and backyards. In one lush yard, an inspector tipped over a kiddie pool and a cooler full of water. Daily aerial spraying for adult mosquitoes and larvae has been approved for the next four weeks over a 10-square-mile area around Wynwood, county officials said. The city of Miami is running extra street-sweeping routes to remove the litter and stagnant water that can serve as breeding grounds. Because of environmental regulations governing which chemicals can be used as insecticides, mosquito control authorities cannot easily switch to another compound if bugs prove resistant to it. Nothing has worked to stop this mosquito elsewhere in the world except for the introduction of mosquitoes modified to pass on genes that kill their offspring, said Michael Doyle, executive director of the Florida Keys Mosquito Control District. And the Food and Drug Administration has not given approval to that approach in the U.S. "We have to totally rethink mosquito control for Aedes aegypti," Doyle said. "It's like a little ninja. It's always hiding." The U.S. government might have underestimated how difficult it would be to control Zika's spread, said University of Florida public health researcher Ira Longini. But he also said there aren't enough of the disease-transmitting mosquitoes living in and around houses to cause long-term or widespread outbreaks in this country. "In defense of the CDC and the government, it's a difficult problem to solve," he said. http://bigstory.ap.org/article/0f970ab193b9413cbdbaa916088e1c00/zika-outbreak-prompts-travel-warning-area-miami

References Rasmussen SA, Jamieson DJ, Honein MA, Petersen LR. Zika virus and birth defects—reviewing the evidence for causality. N Engl J Med 2016;374:1981–7. CrossRef PubMed Brasil P, Pereira JP , Raja Gabaglia C, et al. Zika virus infection in pregnant women in Rio de Janeiro—preliminary report. N Engl J Med 2016. Epub March 4, 2016. CrossRef CDC. Estimated range of Aedes albopictus and Aedes aegypti in the United States, 2016. Atlanta, GA: US Department of Health and Human Services, CDC; 2016. http://www.cdc.gov/zika/pdfs/zika-mosquito-maps.pdf Trussell J. Contraceptive failure in the United States. Contraception 2011;83:397–404. CrossRef PubMed CDC. Zika virus. Atlanta, GA: US Department of Health and Human Services, CDC; 2016. http://www.cdc.gov/zika/index.html Finer LB, Zolna MR. Declines in unintended pregnancy in the United States, 2008–2011. N Engl J Med 2016;374:843–52. CrossRef PubMed Kost K. Unintended pregnancy rates at the state level: estimates for 2010 and trends since 2002. New York, NY: Guttmacher Institute; 2015.https://www.guttmacher.org/sites/default/files/pdfs/pubs/StateUP2010.pdf Curtis KM, Tepper NK, Jatlaoui TC, et al. U.S. medical eligibility criteria for contraceptive use, 2016. MMWR Recomm Rep 2016;65(No. RR-3).PubMed Daniels K, Daugherty J, Jones J, Mosher W. Current contraceptive use and variation by selected characteristics among women aged 15–44: United States, 2011–2013. Natl Health Stat Report 2015;10:1–14. PubMed Parks C, Peipert JF. Eliminating health disparities in unintended pregnancy with long-acting reversible contraception (LARC). Am J Obstet Gynecol 2016;214:681–8. CrossRef PubMed Frost JJ, Zolna MR. Contraceptive needs and services, 2013 update. New York, NY: Guttmacher Institute, 2015.https://www.guttmacher.org/pubs/win/contraceptive-needs-2013.pdf Bearak JM, Finer LB, Jerman J, Kavanaugh ML. Changes in out-of-pocket costs for hormonal IUDs after implementation of the Affordable Care Act: an analysis of insurance benefit inquiries. Contraception 2016;93:139–44. CrossRef PubMed Fox J, Barfield W. Decreasing unintended pregnancy: opportunities created by the Affordable Care Act. JAMA 2016. Epub July 25, 2016. CrossRef Kumar N, Brown JD. Access barriers to long acting reversible contraceptives for adolescents. J Adolesc Health 2016. Epub May 28, 2016. CrossRef CDC. Draft interim CDC Zika response plan (CONUS and Hawaii): initial response to Zika virus. Atlanta, GA: US Department of Health and Human Services, CDC; 2016. http://www.cdc.gov/zika/pdfs/zika-draft-interim-conus-plan.pdf Top * http://www.cdc.gov/zika/transmission/. † http://www.cdc.gov/media/releases/2016/p0729-florida-zika-cases.html; http://www.cdc.gov/zika/intheus/florida-update.html. § http://www.cdc.gov/brfss/annual_data/2013/pdf/overview_2013.pdf. ¶ For BRFSS, women were considered at risk for unintended pregnancy if they were not currently pregnant, were sexually active (not abstinent), and, the last time they had sex, had not had a hysterectomy, did not have a same-sex partner, and did not want a pregnancy. ** http://www.cdc.gov/PRAMS/index.htm. †† For PRAMS, women were considered at risk for unintended pregnancy if they were not currently pregnant, did not want a pregnancy, were sexually active (not abstinent), and did not report another reason they could not get pregnant (i.e., had a same-sex partner, had a hysterectomy/oopherectomy, or were infertile). §§ PRAMS uses a minimum 60% response rate for publication. However, based on the critical need to report surveillance data related to Zika virus, PRAMS provided permission to use a lower response rate threshold. ¶¶ MIHA uses the same definition of unintended pregnancy as PRAMS. *** http://www.cdc.gov/healthyyouth/data/yrbs/methods.htm. ††† Female high school students were considered currently sexually active if they had sexual intercourse with at least one person during the 3 months before the survey. In 2015, 30.1% of female high school students nationwide were currently sexually active.http://www.cdc.gov/mmwr/volumes/65/ss/ss6506a1.htm. §§§ In BRFSS, use of highly effective, permanent contraception ranged from 11.7% to 29.4%; in PRAMS use of highly effective, permanent contraception ranged from 7.5% to 18.8%. YRBSs do not collect information on highly effective, permanent methods of contraception. ¶¶¶ Insurance status was reported at the time of survey, between 4 and 6 months postpartum. **** BRFSS data were excluded if unweighted denominators had <50 respondents or a relative standard error >30%. PRAMS and MIHA data were suppressed if unweighted denominators had <30 respondents; estimates based on <60 respondents were flagged and should be interpreted with caution. YRBS data were suppressed if there were <100 respondents. †††† Need is defined as sexually active women with a family income below 250% of the federal poverty level and all women younger than age 20 years, who are able to conceive and were not intentionally trying to get pregnant. §§§§ https://www.medicaid.gov/federal-policy-guidance/downloads/sho16008.pdf. ¶¶¶¶ BRFSS response rates vary by state (https://www.cdc.gov/brfss/annual_data/2013/pdf/2013_dqr.pdf). PRAMS/MIHA response rates vary by state, but must meet the minimum 55% response threshold to be included; however, the typical minimum response threshold for PRAMS/MIHA is 65% (http://www.cdc.gov/prams/methodology.htm). YRBS response rates vary by state (http://www.cdc.gov/mmwr/preview/mmwrhtml/rr6201a1.htm). ***** The 41 states in the potential range of Zika-carrying mosquitoes are as follows: Alabama, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Georgia, Hawaii, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Minnesota, Mississippi, Missouri, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, Ohio, Oklahoma, Pennsylvania, Rhode Island, South Carolina, Tennessee, Texas, Utah, Vermont, Virginia, West Virginia, and Wisconsin.

BOX. State and jurisdictional-level strategies for increasing access and availability of long-acting reversible contraception (LARC) by state and local agencies, health systems, and providers Facilitate partnership among private and public insurers, device manufacturers, and state agencies Improve acquisition management Streamline service provision Increase efficiency in product purchase Reduce per capita costs Reimburse providers for the full range of contraceptive services Screen for pregnancy intention Provide client-centered contraception counseling Fund full cost of device insertion, removal, and replacement Compensate for device reinsertion of LARC and follow-up Remove logistic and administrative barriers for contraceptive services and supplies* Eliminate policies requiring pre-approval Decrease step therapy restriction or required use of generic drugs before brand-name medication Stock highly effective contraceptive devices in all hospitals and clinics Train health care providers on current insertion and removal techniques for LARC Support use of CDC’s evidence-based contraceptive guidance† Provide quality family planning services§ Increase awareness on use of LARC for most clients of all ages Support youth-friendly reproductive health services Educate health care providers on confidentiality concerns of female adolescents/minors Withhold automated distribution of explanation of benefits to the primary payer Offer extended and weekend hours Provide teen-focused, culturally appropriate materials during health care visits¶,** Engage smaller or rural facilities including community health care centers†† Ensure adequate provider training and supply of LARC Partner with larger facilities to implement contraceptive services Assess client satisfaction with service provision§§ and increase consumer awareness Implement public/private campaigns Provide comprehensive sexual health education in secondary schools *Auerbach J. The 3 buckets of prevention. J Public Health Manag Pract 2016;22:215–8. †Curtis KM, Jatloui TC, Tepper NK. U.S. selected practice recommendations for contraceptive use, 2016. MMWR Recomm Rep 2016;65(No. RR-4). §Gavin L, Moskosky S, Carter M, et al. Providing quality family planning services: recommendations of CDC and the U.S. Office of Population Affairs. MMWR Recomm Rep 2014;63(No. RR-4). ¶Hathaway M, Torres L, Vollett-Krech J, Wohltjen H. Increasing LARC utilization: any woman, any place, any time. Clin Obstet Gynecol 2014;57:718–30. **CDC. Communitywide teen pregnancy prevention initiatives. Atlanta, GA: US Department of Health and Human Services, CDC; 2015.http://www.cdc.gov/teenpregnancy/prevent-teen-pregnancy/ ††Goldberg DG, Wood SF, Johnson K, et al. The organization and delivery of family planning services in community health centers. Womens Health Issues 2015;25:202–8. §§Berwick DM, Nolan TW, Whittington J. The triple aim: care, health, and cost. Health Aff (Millwood) 2008;27:759–69.

TABLE 3. Use of contraception at last sexual intercourse among female students in grades 9–12 who were currently sexually active,* by selected states where mosquito-borne Zika virus transmission might be possible and data were available — Youth Risk Behavior Survey, 2015 State Unweighted no. Highly effective, reversible (LARC)† Moderately effective§ Less effective¶ None % (95% CI) % (95% CI) % (95% CI) % (95% CI) Alabama 204 2.9 (1.2–6.5) 36.2 (27.6–45.7) 39.7 (34.1–45.6) 18.5 (12.6–26.5) Arizona 319 5.4 (2.0–13.8) 23.5 (14.8–35.3) 54.3 (48.1–60.4) 15.3 (9.4–23.9) Arkansas 378 2.4 (0.9–6.2) 30.1 (22.3–39.1) 43.2 (32.8–54.2) 22.8 (18.2–28.3) California 199 5.3 (2.4–11.3) 19.9 (13.0–29.2) 55.3 (48.1–62.2) 12.4 (8.9–16.9) Connecticut 245 3.8 (2.0–7.4) 32.0 (24.6–40.6) 48.9 (40.3–57.6) 12.3 (7.8–18.7) Delaware 399 4.3 (2.4–7.5) 30.8 (25.5–36.6) 48.6 (41.6–55.7) 14.1 (8.0–23.6) Florida 669 2.0 (1.1–3.5) 19.7 (16.1–23.8) 59.9 (54.9–64.7) 16.5 (14.0–19.3) Hawaii 687 6.1 (3.1–11.5) 25.3 (21.3–29.8) 54.8 (48.4–61.1) 11.4 (7.8–16.4) Illinois 363 4.8 (2.7–8.6) 36.7 (27.0–47.6) 46.2 (38.2–54.4) 11.8 (8.0–16.9) Indiana 237 5.0 (2.4–10.0) 32.1 (22.3–43.9) 44.0 (36.2–52.0) 16.3 (10.7–24.0) Kentucky 325 7.8 (3.9–15.1) 36.6 (27.6–46.6) 37.0 (28.0–47.0) 17.5 (13.9–22.0) Maine 1196 6.4 (4.1–9.9) 43.6 (41.2–46.1) 40.5 (36.9–44.2) 8.6 (6.9–10.7) Maryland 5,572 2.6 (2.1–3.2) 27.8 (26.4–29.3) 52.8 (51.2–54.3) 15.3 (14.0–16.7) Massachusetts 388 6.0 (3.6–10.1) 36.2 (30.3–42.6) 48.1 (40.9–55.3) 9.2 (6.7–12.6) Mississippi 246 4.8 (2.6–8.8) 30.8 (23.5–39.3) 49.7 (42.8–56.6) 14.0 (8.5–22.2) Missouri 172 4.9 (2.5–9.2) 35.8 (27.1–45.6) 48.1 (41.8–54.3) 10.5 (5.6–19.0) Nebraska 173 5.0 (2.3–10.2) 28.9 (21.5–37.5) 45.6 (36.2–55.4) 19.0 (11.9–29.0) Nevada 183 2.7 (0.6–11.1) 28.8 (18.3–42.3) 54.8 (40.2–68.6) 13.8 (9.7–19.1) New Hampshire 2,239 6.6 (5.4–8.0) 43.6 (40.1–47.2) 41.6 (38.0–45.3) 7.4 (6.0–9.0) New Mexico 968 7.8 (6.0–10.2) 25.7 (22.3–29.5) 45.9 (41.6–50.3) 17.5 (14.2–21.2) New York 930 4.7 (2.1–10.5) 30.4 (24.8–36.5) 49.6 (41.8–57.5) 13.6 (10.9–16.9) North Carolina 774 1.9 (1.0–3.5) 27.0 (21.3–33.7) 53.9 (45.8–61.8) 15.4 (10.4–22.4) Oklahoma 197 3.8 (1.4–9.6) 23.6 (17.5–31.0) 54.2 (45.9–62.3) 15.4 (9.8–23.3) Pennsylvania 340 1.7 (0.8–3.7) 28.9 (23.5–35.1) 56.8 (51.1–62.3) 12.2 (8.7–16.8) Rhode Island 413 3.7 (1.6–8.1) 31.1 (26.0–36.7) 49.7 (43.0–56.3) 13.4 (9.3–19.1) South Carolina 156 6.5 (1.7–22.3) 32.7 (25.0–41.4) 44.6 (38.5–50.8) 14.2 (10.5–18.9) Vermont 3,028 8.4 (7.5–9.5) 47.0 (45.2–48.8) 36.3 (34.6–38.0) 7.3 (6.4–8.3) West Virginia 278 3.1 (1.3–7.0) 41.7 (34.2–49.6) 41.0 (33.4–49.2) 11.3 (8.5–15.0) Abbreviations: LARC = long-acting, reversible contraception; CI = confidence interval. *Had sexual intercourse with at least one person during the 3 months before the survey. †Highly effective, reversible contraceptive methods or LARC include intrauterine devices (e.g., Mirena or ParaGard) and implants (e.g., Implanon or Nexplanon). §Moderately effective contraceptive methods include oral contraceptive pills or a hormone injection (e.g., Depo-Provera), a transdermal patch (e.g., OrthoEvra), or a vaginal birth control ring (e.g., NuvaRing). ¶Less effective contraceptive methods include condoms to prevent pregnancy, withdrawal, or some other method.

TABLE 2. Use of postpartum contraception* among women aged 15—44 years who recently had a live birth and were at risk for unintended pregnancy,† by selected states where mosquito-borne Zika virus transmission might be possible and data were available — Pregnancy Risk Assessment Monitoring System and Maternal Infant and Health Assessment,§ 2013 State Unweighted no. Weighted no. Highly effective, reversible (LARC)¶ Moderately effective** Less effective†† None % (95% CI) % (95% CI) % (95% CI) % (95% CI) Arkansas 872 29,978 13.1 (9.9–17.2) 35.5 (30.7–40.7) 26.8 (22.4–31.7) 5.8 (3.9–8.6) California 6,037 414,243 15.4 (13.7–17.1) 29.2 (26.9–31.5) 37.6 (35.0–40.2) 6.2 (5.0–7.4) Colorado 1,466 56,393 24.7 (21.8–28.0) 26.0 (22.9–29.2) 30.3 (27.1–33.7) 5.6 (4.2– 7.4) Connecticut 1,021 29,364 20.9 (17.7–24.5) 28.5 (25.0–32.2) 35.2 (31.0–39.7) 7.9 (5.7–10.8) Florida 1,103 179,043 14.7 (12.4–17.4) 32.8 (29.5–36.3) 28.9 (25.8–32.2) 8.0 (6.2–10.1) Georgia 665 58,334 18.5 (14.2–23.6) 39.0 (33.3–45.0) 15.6 (11.7–20.5) 8.7 (5.9–12.5) Hawaii 1,216 15,075 17.8 (15.0–21.0) 33.4 (30.0–37.1) 24.6 (21.5–28.0) 15.3 (12.6–18.4) Illinois 1,156 123,604 16.8 (14.6–19.4) 34.9 (31.9–38.0) 30.3 (27.5–33.2) 7.5 (6.0–9.4) Iowa 1,012 32,421 18.9 (15.7–22.7) 37.3 (33.0–41.8) 24.3 (20.7–28.4) 4.6 (3.1–7.0) Louisiana 1,316 51,925 10.8 (8.7–13.4) 42.7 (39.1–46.4) 23.6 (20.6–27.0) 8.1 (6.3–10.5) Maine 809 10,519 25.5 (22.1–29.1) 28.0 (24.6–31.7) 27.2 (23.8–30.8) 6.9 (5.2–9.3) Maryland 1,047 52,718 12.7 (10.5–15.4) 34.5 (31.2–38.0) 32.1 (28.9–35.5) 10.7 (8.6–13.1) Massachusetts 1,203 57,967 20.8 (17.9–24.0) 33.2 (29.6–37.0) 32.0 (28.5–35.7) 5.0 (3.6–6.9) Minnesota 1,140 56,367 20.0 (17.4–22.8) 31.3 (28.3–34.4) 31.7 (28.7–34.8) 7.1 (5.6–9.1) Missouri 1,030 62,628 19.2 (16.6–22.0) 31.5 (28.4–34.8) 29.0 (26.0–32.2) 5.9 (4.4–7.7) Nebraska 1,352 21,887 16.4 (14.2–18.9) 32.6 (29.7–35.7) 30.7 (27.8–33.6) 8.3 (6.7–10.2) New Hampshire 550 10,793 23.8 (19.7–28.5) 29.0 (24.7–33.8) 27.8 (23.5–32.4) 5.8 (3.9–8.6) New Jersey 742 51,983 6.9 (5.1–9.3) 32.8 (29.2–36.7) 35.4 (31.7–39.3) 11.6 (9.3–14.4) New Mexico 1,435 21,521 26.7 (24.3–29.3) 33.4 (30.8–36.0) 20.8 (18.6–23.2) 5.9 (4.7–7.3) New York§§ 976 87,301 13.6 (10.8–17.1) 32.6 (28.4–37.2) 32.1 (28.0–36.5) 9.4 (6.9–12.5) Ohio 1,237 113,373 14.4 (12.0–17.2) 34.7 (31.3–38.3) 26.3 (23.3–29.6) 8.8 (7.0–11.1) Oklahoma 1,598 44,927 19.3 (16.1–22.9) 35.3 (31.3–39.5) 22.7 (19.4–26.4) 6.2 (4.5–8.4) Pennsylvania 874 110,078 12.5 (10.1–15.2) 33.8 (30.3–37.5) 34.3 (30.8–37.9) 8.2 (6.4–10.5) Rhode Island 1,002 8,604 25.4 (22.6–28.5) 31.8 (28.6–35.0) 24.3 (21.5–27.4) 5.5 (4.1–7.2) Tennessee 632 65,647 13.0 (10.0–16.8) 41.6 (36.8–46.6) 21.3 (17.5–25.6) 6.2 (4.1–9.1) Texas 1,046 322,651 14.7 (12.2–17.7) 32.4 (29.0–36.0) 33.1 (29.6–36.8) 5.4 (3.9–7.4) Utah 1,250 44,789 30.5 (27.4–33.7) 25.8 (22.9–28.9) 29.9 (26.8–33.2) 5.7 (4.3–7.5) Vermont 832 5,040 23.6 (20.7–26.7) 30.2 (27.1–33.6) 30.8 (27.7–34.1) 3.5 (2.4–5.0) Wisconsin 1,277 53,629 16.6 (13.6–20.2) 34.7 (30.7–38.9) 29.6 (25.8–33.8) 6.2 (4.3–8.9) Abbreviations: LARC = long-acting, reversible contraception; CI = confidence interval. *Women using permanent contraception were included in the denominator for all estimates. †Women were considered at risk for unintended pregnancy if they were not currently pregnant, did not want a pregnancy, were sexually active (not abstinent), and did not report another reason they could not get pregnant (i.e., had a same-sex partner, had a hysterectomy/oopherectomy, or were infertile). §MIHA is an annual population-based survey of California resident women with a live birth, with a sample size of 7,010 in 2013. Prevalence and 95% confidence intervals are weighted to represent all women with a live birth in California in 2013. ¶Highly effective, reversible contraceptive methods or LARC include intrauterine devices and implants. **Moderately effective contraceptive methods include hormone injections, contraceptive pills, transdermal contraceptive patch, and vaginal ring. ††Less effective contraceptive methods include diaphragm, condoms (male or female), cervical cap, sponge, withdrawal, spermicide, fertility-based awareness methods, emergency contraception, and “other.” Respondents answering “other” were given the opportunity to write in a response, which was evaluated and reclassified into existing contraceptive method options as appropriate. §§Does not include New York City.

TABLE 1. Use of contraception* at last sexual intercourse among women aged 18–44 years at risk for unintended pregnancy,† by selected states where mosquito-borne Zika virus transmission might be possible and data were available — 10 states§ with state-added questions on reproductive health, Behavioral Risk Factor Surveillance System (BRFSS) survey, 2013, two states¶ with state-added questions on reproductive health (BRFSS, 2012) and five states** with state-added questions on reproductive health (BRFSS, 2011) State Unweighted no. Weighted no. Highly effective, reversible (LARC)†† Moderately effective§§ Less effective¶¶ None % (95% CI) % (95% CI) % (95% CI) % (95% CI) Arizona 307 538,319 5.5 (3.4–8.9) 17.9 (12.5–25.1) 23.6 (17.3–31.2) 32.0 (25.1–39.9) Colorado 587 599,782 15.4 (12.2–19.3) 27.7 (23.6–32.2) 17.1 (13.7–21.1) 15.8 (12.6–19.6) Connecticut 547 440,679 9.6 (6.2–14.6) 25.4 (19.5–32.4) 23.2 (18.0–29.2) 26.1 (20.5–32.6) Florida 762 1,334,658 6.8 (4.6–10.0) 16.6 (13.2–20.6) 25.0 (20.4–30.1) 27.5 (22.9–32.6) Kentucky 884 523,533 6.9 (5.1–9.3) 24.2 (20.5–28.4) 18.0 (14.8–21.7) 22.8 (19.1–27.0) Massachusetts 753 866,004 14.0 (10.6–18.1) 23.9 (19.4–29.2) 20.2 (16.3–24.8) 30.2 (24.6–36.5) Mississippi 461 325,091 6.5 (4.2–9.8) 21.4 (17.2–26.3) 24.9 (20.2–30.4) 18.7 (14.8–23.4) Missouri 418 502,152 7.6 (5.2–11.1) 17.5 (13.3–22.7) 23.4 (18.0–29.8) 25.2 (19.8–31.4) New York 2,728 2,135,002 11.8 (7.3–18.6) 26.0 (20.3–32.7) 26.1 (20.8–32.2) 22.2 (17.6–27.5) North Carolina 676 691,264 8.3 (5.9–11.6) 22.7 (18.5–27.4) 24.3 (20.0–29.2) 24.2 (20.2–28.7) Ohio 658 1,386,428 10.0 (7.3–13.5) 21.6 (17.6–26.2) 18.7 (14.5–23.8) 29.4 (24.9–34.3) Pennsylvania 1,821 1,336,494 7.6 (6.1–9.4) 22.6 (20.1–25.3) 24.7 (21.8–27.9) 24.1 (21.0–27.3) South Carolina 1,356 543,085 6.6 (4.9–9.0) 26.6 (23.3–30.2) 21.0 (18.3–23.9) 22.7 (19.7–26.0) Tennessee 557 592,990 6.5 (3.9–10.6) 13.8 (9.2–20.1) 16.0 (11.1–22.6) 34.3 (27.4–42.0) Texas 347 3,061,291 10.1 (5.5–17.7) 23.1 (17.6–29.8) 17.3 (12.5–23.5) 26.1 (20.2–33.1) Utah 656 256,840 18.9 (15.3–23.0) 20.7 (17.2–24.6) 21.7 (18.0–25.8) 18.9 (15.5–23.0) Vermont 605 70,062 13.8 (11.0–17.3) 30.2 (25.6–35.2) 20.8 (17.0–25.2) 12.3 (9.4–16.0) Abbreviations: LARC = long-acting, reversible contraception; CI = confidence interval. *Women using permanent contraception were included in the denominator for all estimates. †Women were considered at risk for unintended pregnancy if they were not currently pregnant, were sexually active (not abstinent), and, the last time they had sex, had not had a hysterectomy, did not have a same-sex partner, and did not want a pregnancy. §Arizona, Connecticut, Kentucky, Massachusetts, Mississippi, New York (data collected April 2013–March 2014), Ohio, Texas, Utah, and Vermont. ¶Pennsylvania and Colorado. **Florida, Missouri, North Carolina, South Carolina, and Tennessee. ††Highly effective, reversible contraceptive methods or LARC include intrauterine devices and implants. §§Moderately effective contraceptive methods include hormone injections, contraceptive pills, transdermal contraceptive patch, and vaginal ring. ¶¶Less effective contraceptive methods include diaphragm, condoms (male or female), cervical cap, sponge, withdrawal, spermicide, fertility-based awareness methods, emergency contraception, and “other.” Respondents answering “other” were given the opportunity to write in a response, which was evaluated and reclassified into existing contraceptive method options as appropriate. For Connecticut, Kentucky, Massachusetts, Mississippi, Ohio, Texas and Utah, text responses for “other” contraception were evaluated and reclassified into appropriate categories when possible. The text field was not available for other states.

Map Update https://www.google.com/maps/d/edit?hl=en&hl=en&authuser=0&authuser=0&mid=1FlIB7hHnVgGD9TlbSx5HwAj-PEQ

Number of cases reported County/Area Today Year to Date (7/26-28/16) Albany 0 3 Broome 0 1 Clinton 0 1 Columbia 1 1 Dutchess 0 5 Erie 0 4 Lewis 0 1 Monroe 0 5 Nassau 1 31 Niagara 0 1 Oneida 0 2 Onondaga 0 5 Ontario 0 3 Orange 1 3 Otsego 0 1 Putnam 0 1 Rockland 1 7 St Lawrence 0 1 Schenectady 0 1 Suffolk 1 30 Tompkins 0 2 Westchester 0 14 NYS (ex NYC) 5 123 NYC 10 414 NYS Total Confirmed 15 537 NYS Pregnant Registry 0 25 NYS Total 15 562

Discussion During 2011–2013 and 2015, nonpregnant and postpartum women at risk for unintended pregnancy, and sexually active female high school students in states that might be at risk for mosquito-borne transmission of Zika virus, used moderately effective and less effective contraceptive methods most frequently; use of no contraception varied among states. LARC was used by fewer than one fourth of nonpregnant women, approximately one third of women who recently delivered a live birth, and fewer than one tenth of sexually active female high school students. LARC use also varied by state, age group, race/ethnicity, and insurance status. Increasing accessibility of contraceptive services, including LARC, can reduce unintended pregnancy, including the number of pregnancies affected by Zika virus infection among women who are returning, or whose partners are returning, from areas with ongoing Zika virus transmission (5). Despite the availability of a wide range of FDA-approved contraceptives, unintended pregnancy remains common in the United States; the most recent estimates indicate that 45% of all pregnancies are unintended (6), with variation across states (7) and by age group, income, education, and race/ethnicity (6). LARC methods are highly effective, reversible methods for reducing unintended pregnancy, do not depend on user compliance, and are medically appropriate for most female adolescents and adult women (4,8). Nationally, although use of LARC methods nearly doubled in recent years (9), use remains lower than that of other reversible contraceptives such as oral contraceptive pills and condoms (9), and considerable barriers to access and contraceptive method availability remain (10). The most recent estimates for the United States suggest that lower income women had rates of unintended pregnancy up to five times higher than women with higher incomes (6). During 2000–2010, the need for publicly funded contraceptive services increased 17% (11).†††† Although publicly funded providers met approximately 42% of contraceptive need in 2013, unmet need varied by state, suggesting gaps in access to subsidized contraceptive care (11). Among low income women with Medicaid insurance, recent guidance emphasizes provision of contraceptive services without cost-sharing.§§§§ Also, whereas women with private insurance coverage reported decreased out-of-pocket costs for LARC following the 2012 Affordable Care Act requirement for most private health plans to cover contraceptive services, 13% of women continued to cost-share (12), further highlighting differences in access and availability (13). Although federal regulations for publicly funded coverage enable minors to obtain contraceptive care without parental consent, private insurers often follow state laws, which vary by jurisdiction, potentially limiting access (14). To improve access and availability to the full range of contraception, a number of state-level and jurisdictional-level strategies exist and could be adopted by state and local agencies (Box). The findings in this report are subject to at least five limitations. First, information on contraceptive use was self-reported and might be subject to recall or social desirability bias, and response rates varied by state and surveillance system.¶¶¶¶ Second, consistent and correct use of contraception affects effectiveness rates, and this was not measured. Third, population estimates are generalizable only to specific populations for which data are collected; for example, estimates among sexually active female high school students are not generalizable to adolescents who do not attend school. Fourth, the current contraceptive use profile in states might have changed since the data were collected. Finally, only 39 of the 41 states had data from at least one surveillance system, highlighting the need for ongoing collection of state-level data on contraceptive use (3).***** State-level strategies for increasing access to the full range of FDA-approved contraceptive methods and related services can reduce unintended pregnancies among women, including women who might be exposed to Zika virus. CDC supports states in 1) implementing vector control strategies; 2) identifying, diagnosing, and clinically managing infection and exposure among pregnant women; and 3) increasing information about effective contraception to avoid unintended pregnancy (15). Prevention efforts for all women and men of reproductive age include targeted education about Zika virus and its transmission, condom use to avoid sexual transmission to pregnant women, and contraceptive counseling for women who want to delay or avoid pregnancy (15). Because contraception is the primary means to prevent unintended pregnancy for women at risk for Zika virus infection, sexually active nonpregnant women of reproductive age and their sex partners need to have access to all approved contraceptive methods, and these methods need to be readily available and accessible. Top Acknowledgments Behavioral Risk Factor Surveillance System (BRFSS) state collaborators: Rachel (Eddington) Allred, Utah Department of Health; Amy Anderson, Colorado Department of Public Health and Environment; Diane Aye, Connecticut Department of Public Health; Judy Bass, Arizona Department of Health Services; Dana Bernson, Massachusetts Department of Public Health; Carolyn Cass, Pennsylvania Department of Health; James Cassell, North Carolina Department of Health and Human Services; Charlene Collier, Mississippi State Health department; Navina Forsyth, Utah Department of Health; Jill Garratt, Ohio Department of Health; Alison Grace Bui, Colorado Department of Public Health and Environment; Jessie Hammond, Vermont Department of Health; Junwei Jiang, Florida Department of Health; Sarojini Kanotra, Kentucky Department for Public Health; Chelsea Lynes, South Carolina Department of Health and Environmental Control; Ron McAnally, Mississippi State Health Department; Maria McKenna, Massachusetts Department of Public Health; Arthur Pashi, Missouri Department of Health and Senior Services; Alden Small, Pennsylvania Department of Health; Mycroft Sowizral, New York State Department of Health; Carol Stone, Connecticut Department of Public Health; Rebecca Wood, Texas Department of State Health Services; Ransom Wyse, Tennessee Department of Health; Shumei Yun, Missouri Department of Health and Senior Services; Lei Zhang, Mississippi State Health Department. CDC collaborators: Susan Hocevar Adkins, Division of Adolescent and School Health, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP); Danielle Barradas, Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP); Lisa Barrios, Division of Adolescent and School Health, NCHHSTP; Denise Bradford, Division of Adolescent and School Health, NCHHSTP; Kim Burley, Division of Reproductive Health, NCCDPHP; Deborah Dee, Division of Reproductive Health, NCCDPHP; Heather Clayton, Division of Adolescent and School Health, NCHHSTP; Sara Crawford, Division of Reproductive Health, NCCDPHP; Kate Curtis, Division of Reproductive Health, NCCDPHP; William Garvin, Division of Population Health, NCCDPHP; Violanda Grigorescu, Division of Health Informatics and Surveillance, Center for Surveillance, Epidemiology and Laboratory Services; Laura Kann, Division of Adolescent and School Health, NCHHSTP; Sachiko Kuwabara, Division of Emergency Operations, Office of Public Health Preparedness and Response; Tim McManus, Division of Adolescent and School Health, NCHHSTP; Emily Olsen, Division of Adolescent and School Health, NCHHSTP; Ghasi Phillips-Bell, Division of Reproductive Health, NCCDPHP; Ruben Smith, Division of Reproductive Health, NCCDPHP; Tenecia Smith, Office on Smoking and Health, NCCDPHP; Gary Stuart, Division of Reproductive Health, NCCDPHP; Machell Town, Division of Population Health, NCCDPHP; Guixiang Zhao, Division of Population Health, NCCDPHP; CDC Pregnancy Risk Assessment Monitoring System, Division of Reproductive Health. Maternal and Infant Health Assessment (MIHA) collaborators: Michael Curtis, California Department of Public Health; Melanie Dove, California Department of Public Health; Dawnte Early, California Department of Public Health; Katherine Heck, University of California, San Francisco; Kristen Marchi, University of California, San Francisco; Christine Rinki, California Department of Public Health; Monisha Shah, University of California, San Francisco. Pregnancy Risk Assessment Monitoring System (PRAMS) working group: Izza Afgan, Alabama Department of Public Health; Melissa Baker, West Virginia Department of Health and Human Resources; Claudia W. Bingham, Oregon Health Authority; Peggy Brozicevic, Vermont Department of Health; Brenda Coufal, Nebraska Department of Health & Human Services; Oralia Flores, New Mexico Department of Health; Connie Geidenberger, Ohio Department of Health; Jihae Goo, Hawaii Department of Health; Mira Grice Sheff, Minnesota Department of Health; Tanya Guthrie, Texas Department of State Health Services; Peterson Haak, Michigan Department of Health and Human Services; Christopher Hill, Virginia Department of Health; Christopher Huard, Wisconsin Department of Health Services; Brenda Hughes, Mississippi State Health Department; Kathleen Jones-Vessey, North Carolina Department of Health and Human Services; Patricia Kloppenburg, Illinois Department of Public Health; Lakota Kruse, New Jersey Department of Health & Senior Services; David J. Laflamme, New Hampshire Department of Health and Human Services; Ramona Lainhart, Tennessee Department of Health; Alicia Lincoln, Oklahoma Department of Health; Linda Lohdefinck, Washington State Department of Health; Emily Lu, Massachusetts Department of Public Health; Laurie Kettinger, Maryland Department of Health and Mental Hygiene; Sarah Mauch, Iowa Department of Public Health; David McBride, Missouri Department of Health and Senior Services; Mary McGehee, Arkansas Department of Health; Jennifer Morin, Connecticut Department of Public Health; Candace Mulready-Ward, New York City Department of Health and Mental Hygiene; Tony Norwood, Pennsylvania Department of Health; Megan O’Connor, Louisiana Department of Health and Hospitals; Tom Patenaude, Maine Department of Health and Human Services; Kathy Perham-Hester, Alaska Department of Health and Social Services; Anne Radigan, New York State Department of Health; Alyson Shupe, Colorado Department of Public Health and Environment; Alisa Simon, Florida Department of Health; Mike Smith, South Carolina Department of Health and Environmental Control; Amy Spieker, Wyoming Department of Health; Nicole Stone, Utah Department of Health; Karine Tolentino Monteiro, Rhode Island Department of Health; George Yocher, Delaware Department of Health and Social Services; Qun Zheng, Georgia Department of Public Health. Youth Risk Behavior Survey (YRBS) state collaborators: Amberlee Baxa, Nevada Division of Public and Behavioral Health; Fred N. Breukelman, Delaware Division of Public Health; Stephanie Bunge, Kentucky Department of Education; Thad Burk, Oklahoma Department of Health; Tara Cooper, Rhode Island Department of Health; Kathleen Courtney, Arkansas Department of Education; Ellen Essick, North Carolina Department of Public Instruction; Robert M. Fiedler, Department of Health & Mental Hygiene; Jessica H. Gerdes, Illinois State Board of Education; Tori Havins, Arizona Department of Education; Robert Hesia, Hawaii Department of Education; Julane Hill, Nebraska Department of Education; Celeste Jorge, Connecticut Department of Public Health; Sarah Khalidi, Alabama Department of Public Health; Cris Kimbrough, New Mexico Public Education Department; Irene Koffink, New Hampshire Department of Education; Robyn L. Matthews, Indiana Department of Health; Chiniqua N. Milligan, Massachusetts Department of Elementary & Secondary Education; Sabrina B. Moore, South Carolina Department of Education; LaTina Morgan, Mississippi Department of Education; Martha R. Morrissey, New York Education Department; Kristen Murray, Vermont Department of Health; Birgit A. Shanholtzer, West Virginia Department of Education; Nicholas T. Slotterback, Pennsylvania Department of Education; Daniela E. Torres, California Department of Education; Thomas Troelstrup, Florida Department of Health; Janet S. Wilson, Missouri Department of Health and Senior Services; Jean Zimmerman, Maine Department of Education.

Zika virus infection during pregnancy can cause congenital microcephaly and brain abnormalities (1,2). Since 2015, Zika virus has been spreading through much of the World Health Organization’s Region of the Americas, including U.S. territories. Zika virus is spread through the bite of Aedes aegypti or Aedes albopictus mosquitoes, by sex with an infected partner, or from a pregnant woman to her fetus during pregnancy.* CDC estimates that 41 states are in the potential range of Aedes aegypti or Aedes albopictus mosquitoes (3), and on July 29, 2016, the Florida Department of Health identified an area in one neighborhood of Miami where Zika virus infections in multiple persons are being spread by bites of local mosquitoes. These are the first known cases of local mosquito-borne Zika virus transmission in the continental United States.† CDC prevention efforts include mosquito surveillance and control, targeted education about Zika virus and condom use to prevent sexual transmission, and guidance for providers on contraceptive counseling to reduce unintended pregnancy. To estimate the prevalence of contraceptive use among nonpregnant and postpartum women at risk for unintended pregnancy and sexually active female high school students living in the 41 states where mosquito-borne transmission might be possible, CDC used 2011–2013 and 2015 survey data from four state-based surveillance systems: the Behavioral Risk Factor Surveillance System (BRFSS, 2011–2013), which surveys adult women; the Pregnancy Risk Assessment Monitoring System (PRAMS, 2013) and the Maternal and Infant Health Assessment (MIHA, 2013), which surveys women with a recent live birth; and the Youth Risk Behavior Survey (YRBS, 2015), which surveys students in grades 9–12. CDC defines an unintended pregnancy as one that is either unwanted (i.e., the pregnancy occurred when no children, or no more children, were desired) or mistimed (i.e., the pregnancy occurred earlier than desired). The proportion of women at risk for unintended pregnancy who used a highly effective reversible method, known as long-acting reversible contraception (LARC), ranged from 5.5% to 18.9% for BRFSS-surveyed women and 6.9% to 30.5% for PRAMS/MIHA–surveyed women. The proportion of women not using any contraception ranged from 12.3% to 34.3% (BRFSS) and from 3.5% to 15.3% (PRAMS/MIHA). YRBS data indicated that among sexually active female high school students, use of LARC at last intercourse ranged from 1.7% to 8.4%, and use of no contraception ranged from 7.3% to 22.8%. In the context of Zika preparedness, the full range of contraceptive methods approved by the Food and Drug Administration (FDA), including LARC, should be readily available and accessible for women who want to avoid or delay pregnancy. Given low rates of LARC use, states can implement strategies to remove barriers to the access and availability of LARC including high device costs, limited provider reimbursement, lack of training for providers serving women and adolescents on insertion and removal of LARC, provider lack of knowledge and misperceptions about LARC, limited availability of youth-friendly services that address adolescent confidentiality concerns, inadequate client-centered counseling, and low consumer awareness of the range of contraceptive methods available. BRFSS is a cross-sectional, random-digit–dialed, state-based telephone survey that collects data on risk behaviors and preventive health practices among adult respondents living in all 50 states, the District of Columbia, Puerto Rico, Guam, and the U.S. Virgin Islands.§ Data from 17 states that might be at risk for mosquito-borne transmission of Zika virus (3) and had implemented questions on self-reported contraceptive use as part of the BRFSS Family Planning module in 2011 or as state-added questions in 2012 or 2013 were used to estimate use of contraception among women aged 18–44 years at risk for unintended pregnancy.¶ PRAMS is an ongoing state-based and population-based surveillance system designed to monitor selected self-reported maternal behaviors and experiences that occur before, during, and after pregnancy among women who recently delivered a live-born infant.** Data from 28 PRAMS states, reporting in 2013, were used to estimate contraceptive use at the time of the survey (4–6 months postpartum) among women aged 15–44 years with a recent live birth who were at risk for unintended pregnancy.†† PRAMS sites were included if they might be at risk for mosquito-borne transmission of Zika virus (3) and achieved a weighted response rate of ≥55%.§§ The 2013 MIHA was used to estimate contraceptive use for postpartum women in California. Using methods comparable to PRAMS, MIHA is an annual, statewide-representative survey of women with a recent live birth.¶¶ YRBSs are conducted by state health and education agencies among representative samples of students in grades 9–12, to monitor health-risk behaviors, including sexual behaviors related to unintended pregnancy and sexually transmitted diseases.*** Data from 2015 YRBSs conducted in 28 states that might be at risk for mosquito-borne transmission of Zika virus (3) were used to describe contraceptive use among female high school students at last sexual intercourse.††† For all data sources, contraceptive use was classified according to the estimated percentage of users who experience pregnancy during the first year of typical use as highly effective (<1%), moderately effective (6%–10%), and less effective (>10%) (4). Among women reporting more than one contraceptive method, the most effective method was coded. Highly effective, permanent contraceptive methods included female sterilization, tubal ligation, or partner vasectomy. Highly effective LARC methods included intrauterine devices (IUDs) and contraceptive implants. Moderately effective contraceptive methods included hormone injections, contraceptive pills, transdermal contraceptive patches, and vaginal rings. Less effective methods included diaphragm, condoms (male or female), cervical cap, sponge, withdrawal, spermicide, fertility-based awareness methods, emergency contraception, and “other.” Data for the use of permanent contraceptive methods, although included in the denominator for calculating percentages, are not presented because women reporting female sterilization or partner vasectomy do not need ongoing contraceptive services.§§§ Weighted prevalence estimates and 95% confidence intervals for contraceptive use were calculated overall and by age group, as appropriate (BRFSS: ages 18–24, 25–34, and 35–44 years; PRAMS/MIHA: ages 15–19, 20–24, 25–34, and 35–44 years) and by race/ethnicity (non-Hispanic white [white], non-Hispanic black [black], and Hispanic). For all surveys, non-Hispanic other race was included in the denominator, but not presented because of small sample sizes. PRAMS/MIHA data were used to estimate the prevalence of contraceptive use by insurance status (private insurance, Medicaid, and none)¶¶¶; other insurance was not presented because of small sample sizes. Estimates were excluded when they did not meet the reliability standard established for each surveillance system.**** In the 17 states for which BRFSS data were available, use of LARC at last sexual intercourse among women aged 18–44 years at risk for unintended pregnancy ranged from 5.5% (Arizona) to 18.9% (Utah) (Table 1). The proportion of women at risk for unintended pregnancy who used no contraception was lowest in Vermont (12.3%) and highest in Tennessee (34.3%). For all states, moderately and less effective contraception use was lower among older women (available at https://stacks.cdc.gov/view/cdc/40511). Use of less effective contraception was more common among Hispanic women than among white women (available at https://stacks.cdc.gov/view/cdc/40511). PRAMS and MIHA data indicated that the proportion of women aged 15–44 years at risk for unintended pregnancy using LARC during the postpartum period ranged from 6.9% (New Jersey) to 30.5% (Utah) (Table 2) and was typically highest among adolescents aged 15–19 years (available athttps://stacks.cdc.gov/view/cdc/40512). The proportion of postpartum women at risk for unintended pregnancy who did not use contraception ranged from 3.5% (Vermont) to 15.3% (Hawaii). In general, use of LARC and moderately effective contraception was lower in older women (available athttps://stacks.cdc.gov/view/cdc/40512). The proportion of women using less effective contraceptive methods tended to be higher among white and Hispanic women than black women (available at https://stacks.cdc.gov/view/cdc/40512). Among women with no insurance, use of LARC ranged from 5.3% (New Jersey) to 34.2% (Utah) (available at https://stacks.cdc.gov/view/cdc/40513). YRBS data indicated that among currently sexually active female high school students in 28 states, LARC use ranged from <2% (North Carolina and Pennsylvania) to 8.4% (Vermont) (Table 3). Use of less effective contraceptive methods ranged from 36.3% (Vermont) to 59.9% (Florida); the proportion of sexually active female high school students not using any contraception was lowest in Vermont (7.3%) and highest in Arkansas (22.8%). Limited data were available to describe sexually active female high school students using contraception by method effectiveness and race/ethnicity (available athttps://stacks.cdc.gov/view/cdc/40514).

Summary What is known about this topic? Zika virus is transmitted through the bite of an Aedes species mosquito, sex with an infected partner, or from a pregnant woman to her fetus. Zika virus infection during pregnancy is a cause of congenital microcephaly and other severe fetal brain defects. It has also been associated with eye defects, hearing loss, and impaired growth. Nearly half of all pregnancies in the United States are unintended. Among nonpermanent contraceptive methods, long-acting reversible contraception (LARC) is the most effective contraceptive option for preventing unintended pregnancy. What is added by this report? State-based estimates of contraception use are provided for nonpregnant and postpartum women at risk for unintended pregnancy and sexually active female high school students. Among these populations, use of moderate and less effective contraception was most common; use of no contraceptive method and use of LARC varied by state, age group, and race/ethnicity. What are the implications for public health practice? State and local strategies are needed to increase access to contraceptive methods and related services, reduce the risk for unintended pregnancy, and minimize the number of pregnancies affected by Zika infection. Potentially effective strategies include addressing policies on high device costs and provider reimbursement, comprehensive provider training on insertion and removal of LARC, provision of youth-friendly services, support to resource-challenged jurisdictions, client-centered counseling and assessment of patient satisfaction, and increased consumer awareness of the full range of contraceptive methods to delay or avoid pregnancy.

Sheree L. Boulet, DrPH1; Denise V. D’Angelo, MPH1; Brian Morrow, MA1; Lauren Zapata, PhD1; Erin Berry-Bibee, MD1; Maria Rivera, MPH3; Sascha Ellington, MSPH1; Lisa Romero, DrPH1; Eva Lathrop, MD4; Meghan Frey, MA, MPH2; Tanya Williams, MPH1; Howard Goldberg, PhD1; Lee Warner, PhD1; Leslie Harrison, MPH1; Shanna Cox, MSPH1; Karen Pazol, PhD1; Wanda Barfield, MD1; Denise J. Jamieson, MD1; Margaret A. Honein, PhD2; Charlan D. Kroelinger, PhD1 Corresponding author: Charlan Kroelinger, [email protected], 770-488-6545. Top 1Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, CDC; 2Division of Congenital and Developmental Disorders, National Center on Birth Defects and Developmental Disabilities, CDC; 3Oak Ridge Institute for Science and Education;4Division of Global Health Protection, Center for Global Health, CDC.